首页> 外文期刊>Cell biochemistry and biophysics >Bumetanide Hyperpolarizes Madin-Darby Canine Kidney Cells and Enhances Cellular Gentamicin Uptake by Elevating Cytosolic Ca2+ Thus Facilitating Intermediate Conductance Ca2+-Activated Potassium Channels
【24h】

Bumetanide Hyperpolarizes Madin-Darby Canine Kidney Cells and Enhances Cellular Gentamicin Uptake by Elevating Cytosolic Ca2+ Thus Facilitating Intermediate Conductance Ca2+-Activated Potassium Channels

机译:布美他尼通过升高胞浆中的Ca2 +来使Madin-Darby犬肾细胞超极化并增强细胞对庆大霉素的摄取,从而促进Ca2 +激活的钾通道的中途传导。

获取原文
获取原文并翻译 | 示例
           

摘要

Loop diuretics such as bumetanide and furosemide enhance aminoglycoside ototoxicity when co-administered to patients and animal models. The underlying mechanism(s) is poorly understood. We investigated the effect of these diuretics on cellular uptake of aminoglycosides, using Texas Red-tagged gentamicin (GTTR), and intracellular/whole-cell recordings of Madin-Darby canine kidney (MDCK) cells. We found that bumetanide and furosemide dose-dependently enhanced cytoplasmic GTTR fluorescence by ~60 %. This enhancement was suppressed by La3+, a non-selective cation channel (NSCC) blocker, and by K+ channel blockers Ba2+ and clotrimazole, but not by tetraethylammonium (TEA), 4-aminopyridine (4-AP) or glipizide, nor by Cl- channel blockers diphenylamine-2-carboxylic acid (DPC), niflumic acid (NFA), and CFTRinh-172. Bumetanide and furosemide hyperpolarized MDCK cells by ~14 mV, increased whole-cell I/V slope conductance; the bumetanide-induced net current I/V showed a reversal potential (Vr) ~-80 mV. Bumetanide-induced hyperpolarization and I/V change was suppressed by Ba2+ or clotrimazole, and absent in elevated [Ca2+]i, but was not affected by apamin, 4-AP, TEA, glipizide, DPC, NFA, or CFTRinh-172. Bumetanide and furosemide stimulated a surge of Fluo-4-indicated cytosolic Ca2+. Ba2+ and clotrimazole alone depolarized cells by ~18 mV and reduced I/V slope with a net current Vr near -85 mV, and reduced GTTR uptake by ~20 %. La3+ alone hyperpolarized the cells by ~-14 mV, reduced the I/V slope with a net current Vr near -10 mV, and inhibited GTTR uptake by ~50 %. In the presence of La3+, bumetanide-caused negligible change in potential or I/V. We conclude that NSCCs constitute a major cell entry pathway for cationic aminoglycosides; bumetanide enhances aminoglycoside uptake by hyperpolarizing cells that increases the cation influx driving force; and bumetanide-induced hyperpolarization is caused by elevating intracellular Ca2+ and thus facilitating activation of the intermediate conductance Ca2+-activated K+ channels.
机译:与患者和动物模型合用时,利尿剂如布美他尼和呋塞米可增强氨基糖苷的耳毒性。根本的机制了解甚少。我们使用得克萨斯州红标签的庆大霉素(GTTR)和Madin-Darby犬肾(MDCK)细胞的细胞内/全细胞记录,研究了这些利尿剂对氨基糖苷类细胞摄取的影响。我们发现布美他尼和呋塞米剂量依赖性地将细胞质GTTR荧光提高了〜60%。 La3 +(一种非选择性阳离子通道(NSCC)阻滞剂)和K +通道阻滞剂Ba2 +和克霉唑抑制了这种增强,但四乙基铵(TEA),4-氨基吡啶(4-AP)或格列吡嗪却没有抑制,Cl-通道阻滞剂二苯胺-2-羧酸(DPC),尼氟酸(NFA)和CFTRinh-172。布美他尼和呋塞米使超极化的MDCK细胞增加约14 mV,增加了全细胞I / V斜率电导;布美他尼引起的净电流I / V显示出反向电位(Vr)〜-80 mV。 B2 +或克霉唑抑制了布美他尼诱导的超极化和I / V变化,升高的[Ca2 +] i中不存在布美他尼诱导的超极化和I / V变化,但不受阿帕明,4-AP,TEA,格列吡嗪,DPC,NFA或CFTRinh-172的影响。布美他尼和呋塞米刺激了Fluo-4指示的胞质Ca2 +激增。单独的Ba2 +和克霉唑使细胞去极化约18 mV,I / V斜率降低,净电流Vr接近-85 mV,GTTR吸收降低约20%。单独的La3 +将细胞超极化约-14 mV,以-10 mV的净电流Vr降低I / V斜率,并抑制GTTR摄取约50%。在存在La3 +的情况下,布美他尼导致电位或I / V的变化可忽略不计。我们得出结论,NSCCs构成了阳离子氨基糖苷类的主要细胞进入途径。布美他尼通过使细胞超极化来增加氨基糖苷的摄取,从而增加阳离子流入的驱动力;布美他尼诱导的超极化是由于细胞内Ca2 +升高,从而促进了中间电导Ca2 +激活的K +通道的激活。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号